Search Within

Sloan Kettering Institute Postdocs

  1. "Elisa De Stanchina"
Formats
  1. Journal Article (170)
  2. Meeting Abstract (71)
  3. Research Letter (2)
Groups
  1. GSK Faculty (227)
  2. Department of Medicine (180)
  3. Solid Tumor Oncology Division (148)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (121)
  5. Human Oncology and Pathogenesis Program (118)
  6. Sloan Kettering Institute Faculty (114)

More Groups

People
  1. Elisa De Stanchina (243)
  2. Charles Rudin (59)
  3. Marc Ladanyi (37)
  4. Marissa Mattar (37)
  5. Inna Khodos (34)
  6. Romel Somwar (33)

More People

Years
  1. 2025 (6)
  2. 2024 (26)
  3. 2023 (19)
  4. 2022 (43)
  5. 2021 (37)
  6. 2020 (26)

More Years

Publications
  1. Cancer Research (35)
  2. Cancer Discovery (20)
  3. Clinical Cancer Research (13)
  4. Journal of Thoracic Oncology (13)
  5. Cancer Cell (10)
  6. Nature (10)

More Publications

Publishers
  1. American Association for Cancer Research (78)
  2. Nature Publishing Group (33)
  3. Cell Press (28)
  4. Elsevier Inc. (22)
  5. American Society of Clinical Oncology (8)
  6. American Society of Hematology (8)

More Publishers

Results (243)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma
    Meeting Abstract

    Ladanyi, M.; Yang, S. R.; Zhang, T.; de Stanchina, E.; Somwar, R.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
    Journal Article

    Krishnamoorthy, G. P.; Glover, A. R.; Untch, B. R.; Sigcha-Coello, N.; Xu, B.; Vukel, D.; Liu, Y.; Tiedje, V.; Pineda, J. M. B.; Berman, K.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Metabolic engineering to facilitate anti-tumor immunity
    Journal Article

    Schild, T.; Wallisch, P.; Zhao, Y.; Wang, Y. T.; Haughton, L.; Chirayil, R.; Pierpont, K.; Chen, K.; Nunes-Violante, S.; Cross, J.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • Pharmacological restoration of GTP hydrolysis by mutant RAS
    Journal Article

    Cuevas-Navarro, A.; Pourfarjam, Y.; Hu, F.; Rodriguez, D. J.; Vides, A.; Sang, B.; Fan, S.; Goldgur, Y.; de Stanchina, E.; Lito, P.
    Nature (2025)

    Fulltext@MSK | Save
  • Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung tumors
    Meeting Abstract

    Redin, E.; Manoj, P.; Qiu, J.; Zhong, H.; Vural, S.; Zhan, Y.; Koche, R.; Socci, N.; DeStanchina, E.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • SMARCA4 controls state plasticity in SCLC through regulation of neuroendocrine transcription factors and REST splicing
    Meeting Abstract

    Redin, E.; Sridhar, H.; Zhan, Y.; Pereira Mello, B.; Zhong, H.; Manoj, P.; Linkov, I.; Qiu, J.; Koche, R. P.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Tumor adaptation to PI3K inhibition and its stability increases as a function of time and is overcome by combined inhibiting Bcl2 family proteins
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Sharma, M.; Solomon, H.; De Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save